Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,513 articles

Articles by Daniel Marsh

Dow Hits Record, Chip Stocks Slide in Pre-Holiday Trading
Markets

Dow Hits Record, Chip Stocks Slide in Pre-Holiday Trading

The Dow reached a new high while chip stocks dragged the Nasdaq lower in a mixed session ahead of the Independence Day holiday.

MU NVDA LRCX AAPL TSLA META SNDK SPY QQQ DIA IWM
Avis Budget Stock Surges 11% on $650M Settlement Details
Markets

Avis Budget Stock Surges 11% on $650M Settlement Details

Avis Budget Group shares surged 11.3% after a filing revealed a $650 million settlement with Pentwater, boosting market cap by nearly $585 million.

CAR HTZ XLY SPY
Zhongchao Shares Surge in After-Hours Trading Following Reverse Stock Split
Markets

Zhongchao Shares Surge in After-Hours Trading Following Reverse Stock Split

Zhongchao Inc. (NASDAQ:ZCMD) shares surged 199% in after-hours trading after a 1-for-3 reverse split, with volume nearly 19 times the new share count.

ZCMD
Recursion Pharmaceuticals Gains Amid Founder Sale Filing, Short Interest Remains Elevated
Markets

Recursion Pharmaceuticals Gains Amid Founder Sale Filing, Short Interest Remains Elevated

Recursion Pharmaceuticals (RXRX) shares gained 3.54% on Thursday, even as the broader market slipped, with a founder's planned sale representing a tiny fraction of volume. Short interest remains high at 39.11% of float.

RXRX XBI IBB QQQ SPY
SFO Flight Delays Pressure United Airlines Operations
Markets

SFO Flight Delays Pressure United Airlines Operations

SFO saw 368 delays and five cancellations on July 2, with FAA holding inbound flights for 42 minutes. United Airlines (UAL) handles 48.7% of SFO enplanements, facing investor scrutiny.

UAL ALK DAL
Moderna Surges 10% as Flu Vaccine Hopes Add $2.9B to Market Cap
Markets

Moderna Surges 10% as Flu Vaccine Hopes Add $2.9B to Market Cap

Moderna shares surged over 10% in after-hours trading, adding roughly $2.9 billion in market value as investor enthusiasm for its flu vaccine pipeline continues to build.

MRNA NVAX PFE GSK IBB XBI SPY QQQ
AbbVie Surges $17.8 Billion in Market Cap, Surpassing Apogee Deal Value
Markets

AbbVie Surges $17.8 Billion in Market Cap, Surpassing Apogee Deal Value

AbbVie shares soared 3.99% to $261.07, adding $17.8B in market value—more than the $10.9B Apogee deal. The stock now trades above analyst targets, setting up a key Q2 earnings report.

ABBV APGE XLV JNJ PFE AMGN
Comcast Stock Stalls as Broadband Woes Offset Spin-Off Optimism
Markets

Comcast Stock Stalls as Broadband Woes Offset Spin-Off Optimism

Comcast shares closed slightly higher Thursday, but gains remain muted as broadband concerns temper excitement over the planned NBCUniversal separation.

CMCSA
Applied Optoelectronics Shares Slide 13% on $94M Cleanroom Cash Outlay
Markets

Applied Optoelectronics Shares Slide 13% on $94M Cleanroom Cash Outlay

Applied Optoelectronics shares tumbled nearly 13% after a filing revealed a $94.1 million cleanroom contract, representing about 21% of its cash and restricted cash as of March 31.

AAOI COHR LITE CIEN SOXX QQQ
JNJ Closes Above Analyst Average After Dow Rebalancing
Markets

JNJ Closes Above Analyst Average After Dow Rebalancing

Johnson & Johnson shares ended Thursday at $263.04, gaining 3.57% and closing above the average analyst target of $262.10 following the Dow rebalancing.

JNJ
T1 Energy Shares Slide as Expiring Warrants, Convertible Notes Weigh
Markets

T1 Energy Shares Slide as Expiring Warrants, Convertible Notes Weigh

T1 Energy shares dropped 6.8% to $8.56 as the market focuses on next week's warrant expiration and in-the-money convertible notes, with key price levels under watch.

TE SPY
Pfizer Gains as 7% Yield Attracts, China Trial Scrutiny Looms
Markets

Pfizer Gains as 7% Yield Attracts, China Trial Scrutiny Looms

Pfizer (PFE) shares climbed 2.1% on Thursday, supported by a high dividend yield, but a U.S. House committee probe into its China trial data adds uncertainty.

PFE SPY XLV MRK ABBV BMY LLY